JF

Jeff Farrow

Chief Financial Officer and Chief Strategy Officer

Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Pipeline

DrugIndicationPhase
XDEMVY (TP-03)Demodex BlepharitisCommercial
TP-03Meibomian Gland Disease (MGD)Phase 2b
TP-04Ocular RosaceaPhase 2
TP-05Lyme Disease PreventionPhase 1